Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials

Rahimy Ehsan; Baker Keith; Thompson Desmond; Saroj Namrata

首页> 外文期刊>Investigative ophthalmology & visual science >Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials

【24h】

Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials

机译：全身二肽基肽酶-4（DPP-4）抑制剂对Vista和生动试验的糖尿病黄斑水肿（DME）治疗结果的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共2页
作者
Rahimy Ehsan; Baker Keith; Thompson Desmond; Saroj Namrata;
展开▼
作者单位

Palo Alto Med Fdn Palo Alto CA USA;

Regeneron Pharmaceut Inc Tarrytown CA USA;

Regeneron Pharmaceut Inc Tarrytown CA USA;

Regeneron Pharmaceut Inc Tarrytown CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials [J] . Rahimy Ehsan, Baker Keith, Thompson Desmond, Investigative ophthalmology & visual science . 2018,第9期

机译：全身二肽基肽酶-4（DPP-4）抑制剂对Vista和生动试验的糖尿病黄斑水肿（DME）治疗结果的影响
2. Impact of Presence or Absence of Posterior Vitreous Detachment (PVD) at Baseline on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials [J] . Kasi Sundeep, Ho Allen Investigative ophthalmology & visual science . 2017,第8期

机译：在Vista和生动试验中，在糖尿病黄斑水肿（DME）的基线上存在或不存在后玻璃体脱离（PVD）的影响
3. Impact of Presence or Absence of Posterior Vitreous Detachment (PVD) at Baseline on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials [J] . Kasi Sundeep, Ho Allen Investigative ophthalmology & visual science . 2017,第8期

机译：在Vista和生动试验中，在糖尿病黄斑水肿（DME）的基线上存在或不存在后玻璃体脱离（PVD）的影响
4. Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy [C] . Eka Gunarti Ningsih, Muhammad Fauzi Hidayat, Usman Sumo Friend Tambunan International work-conference on bioinformatics and biomedical engineering . 2019

机译：基于片段的药物设计，发现二肽基肽酶-4（DPP-4）的新型抑制剂作为2型糖尿病治疗的潜在药物
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data [O] . Focke Ziemssen, Patricio G. Schlottman, Jennifer I. Lim, 2016

机译：糖尿病性黄斑水肿患者玻璃体腔注射阿柏西普治疗的启动：VIVID-DME和VISTA-DME数据综述
7. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data [O] . Focke Ziemssen, Patricio G. Schlottman, Jennifer I. Lim, 2016

机译：糖尿病性黄斑水肿患者玻璃体腔注射阿柏西普治疗的启动：VIVID-DME和VISTA-DME数据综述

Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials

著录项

相似文献

相关主题

期刊订阅